81 related articles for article (PubMed ID: 33571749)
1. Euglycemic diabetic ketoacidosis associated with SGLT2i use: Case series.
Puls HA; Haas NL; Franklin BJ; Theyyunni N; Harvey CE
Am J Emerg Med; 2021 Jun; 44():11-13. PubMed ID: 33571749
[TBL] [Abstract][Full Text] [Related]
2. Euglycemic Diabetic Ketoacidosis: Experience with 44 Patients and Comparison to Hyperglycemic Diabetic Ketoacidosis.
Sell J; Haas NL; Korley FK; Cranford JA; Bassin BS
West J Emerg Med; 2023 Nov; 24(6):1049-1055. PubMed ID: 38165186
[TBL] [Abstract][Full Text] [Related]
3. A retrospective analysis of the incidence, outcome and factors associated with the occurrence of euglycemic ketoacidosis in diabetic patients on sodium glucose co-transporter - 2 inhibitors undergoing cardiac surgery.
Murugesan KB; Balakrishnan S; Arul A; Ramalingam S; Srinivasan M
Ann Card Anaesth; 2022; 25(4):460-465. PubMed ID: 36254911
[TBL] [Abstract][Full Text] [Related]
4. Euglycemic diabetic ketoacidosis: The paradox of delayed correction of acidosis.
Albert SG; Shrestha E; Wood EM
Diabetes Metab Syndr; 2023 Sep; 17(9):102848. PubMed ID: 37651890
[TBL] [Abstract][Full Text] [Related]
5. "Normal but Catastrophic" Euglycemic Diabetic Ketoacidosis Precipitated by Sodium-Glucose Cotransporter-2 Inhibitor Use: A Case Report.
Sarno MJF; Hernandez DPF; Matulac MO
Cureus; 2023 Nov; 15(11):e49236. PubMed ID: 38143642
[TBL] [Abstract][Full Text] [Related]
6. The Significance of Precise Diabetes Diagnosis: A Case of Euglycemic Diabetic Ketoacidosis Induced by the Introduction of Empagliflozin with Simultaneous Reduction of Insulin Dosage.
Bińczyk W; Dróżdż O; Siudek B; Głuszczyk AM; Plizga JI; Grajnert FJ
Eur J Case Rep Intern Med; 2024; 11(6):004567. PubMed ID: 38846667
[TBL] [Abstract][Full Text] [Related]
7. Sodium-glucose cotransporter-2-induced euglycemic diabetic ketoacidosis unmasks latent autoimmune diabetes in a patient misdiagnosed with type 2 diabetes mellitus: a case report.
Vadasz B; Arazi M; Shukha Y; Koren O; Taher R
J Med Case Rep; 2021 Feb; 15(1):62. PubMed ID: 33581735
[TBL] [Abstract][Full Text] [Related]
8. Euglycemic Ketoacidosis in Two Patients Without Diabetes After Introduction of Sodium-Glucose Cotransporter 2 Inhibitor for Heart Failure With Reduced Ejection Fraction.
Umapathysivam MM; Gunton J; Stranks SN; Jesudason D
Diabetes Care; 2024 Jan; 47(1):140-143. PubMed ID: 37988720
[TBL] [Abstract][Full Text] [Related]
9. [Sodium glucose cotransporter-2 inhibitors (SGLT2i) and risk of ketoacidosis].
Nordvall LM; Ekstedt B; Schneede J
Lakartidningen; 2024 Feb; 121():. PubMed ID: 38369865
[TBL] [Abstract][Full Text] [Related]
10. Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors.
Chow E; Clement S; Garg R
BMJ Open Diabetes Res Care; 2023 Oct; 11(5):. PubMed ID: 37797963
[TBL] [Abstract][Full Text] [Related]
11. Diabetic Ketoacidosis as an Effect of Sodium-Glucose Cotransporter 2 Inhibitor: Real World Insights.
Baek HS; Jeong C; Yang Y; Lee J; Lee J; Lee SH; Cho JH; Sohn TS; Son HS; Yoon KH; Lee EY
Diabetes Metab J; 2024 Jun; ():. PubMed ID: 38853537
[TBL] [Abstract][Full Text] [Related]
12. Ketoacidosis and SGLT2 Inhibitors: A Narrative Review.
Morace C; Lorello G; Bellone F; Quartarone C; Ruggeri D; Giandalia A; Mandraffino G; Minutoli L; Squadrito G; Russo GT; Marini HR
Metabolites; 2024 May; 14(5):. PubMed ID: 38786741
[TBL] [Abstract][Full Text] [Related]
13. Euglycemic Diabetic Keto Acidosis in a Type 1 Diabetic Patient After Glucose Like Peptide-1 Administration: A Case Presentation.
Widhalm C; Pulido V
J Investig Med High Impact Case Rep; 2023; 11():23247096231206333. PubMed ID: 37843126
[TBL] [Abstract][Full Text] [Related]
14. Inpatient case characteristics of SGLT2 inhibitor-associated diabetic ketoacidosis: a retrospective study.
Yang Z; Zhang W; Chen H; Peng Q
Eur J Hosp Pharm; 2024 Jun; ():. PubMed ID: 38844329
[TBL] [Abstract][Full Text] [Related]
15. Sodium-Glucose Cotransporter-2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis in a Type 2 Diabetic Patient.
Haddadin R; Aboujamra D; Iraninezhad H
Cureus; 2023 Dec; 15(12):e51184. PubMed ID: 38283482
[TBL] [Abstract][Full Text] [Related]
16. Balancing Risks and Benefits: Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis.
Kleinjan JP; Blom J; van Beek AP; Bouma HR; van Dijk PR
Metabolites; 2024 Mar; 14(3):. PubMed ID: 38535322
[TBL] [Abstract][Full Text] [Related]
17. Risk of Euglycemic Diabetic Ketoacidosis in Patients Taking Sodium Glucose Transporter 2 Inhibitors Undergoing Endoscopies.
Steinhorn B; Cao S; Richter J; White R; Wiener-Kronish J
Anesthesiology; 2023 Nov; 139(5):705-707. PubMed ID: 37815471
[No Abstract] [Full Text] [Related]
18. Life-threatening coronary vasospasm in patients with type 2 diabetes with SGLT2 inhibitor-induced euglycemic ketoacidosis: a report of two consecutive cases.
Kawahara J; Kaku B; Yagi K; Kitagawa N; Yokoyama M; Wakabayashi Y; Senda S; Takata H; Hiraiwa Y
Diabetol Int; 2024 Jan; 15(1):135-140. PubMed ID: 38264228
[TBL] [Abstract][Full Text] [Related]
19. Incidence of sodium-glucose cotransporter-2 inhibitor-associated perioperative ketoacidosis in surgical patients: a prospective cohort study.
Seki H; Kuratani N; Shiga T; Iwasaki Y; Karita K; Yasuda K; Yamamoto N; Nakanishi Y; Shigematsu K; Kobayashi K; Saito J; Kondo I; Yaida N; Watanabe H; Higashi M; Shirasaka T; Doshu-Kajiura A; Edanaga M; Tanaka S; Ikumi S; Ito S; Okada M; Yorozu T;
J Anesth; 2024 Mar; ():. PubMed ID: 38494577
[TBL] [Abstract][Full Text] [Related]
20. Defining Physiological Ketosis Following Very-Low-Calorie Diets.
Mollah T; Gillespie C; Cocco A; Taylor L; Chong L; Hii MW
J Surg Res; 2023 Oct; 290():197-202. PubMed ID: 37271067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
